Dans
Response: A dozen pharmaceutical laboratories have been fined in France for insufficient stock of medications. The sanctions were imposed by the French medicines agency (ANSM) after an investigation found that the laboratories had not respected the legal obligation to maintain a sufficient stock of medications in order to ensure continuous supply to patients. The fines amount to several million euros. The laboratories that were sanctioned include both French and international companies. The ANSM stated that the sanctions were intended to send a strong message to the industry about the importance of ensuring a stable supply of medications to patients.